To include your compound in the COVID-19 Resource Center, submit it here.

Ribomic test in Tokyo

Preclinical RNA play Ribomic looks to become Japan's first biotech IPO of 2014

Ribomic Inc. hopes to become 2014's first biotech IPO on the Tokyo Stock Exchange this month.

Last week, Ribomic set the price range at ¥2,000-¥2,300 for its IPO on the exchange's

Read the full 301 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers